• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外检测和鉴定尤因肉瘤 SK-ES-1 细胞中的侧群。

Detection and characterization of side population in Ewing's sarcoma SK-ES-1 cells in vitro.

机构信息

Institute of Orthopaedics and Traumatology of PLA of China, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710032, PR China.

出版信息

Biochem Biophys Res Commun. 2010 Jan 1;391(1):1062-6. doi: 10.1016/j.bbrc.2009.12.020. Epub 2009 Dec 10.

DOI:10.1016/j.bbrc.2009.12.020
PMID:20004177
Abstract

Dye exclusion is a valuable technique to isolate cancer stem cells (CSCs) based on an ability of stem cell to efflux fluorescent DNA-binding dye, especially for tumors without unique surface markers. It has been proven that side population (SP) cells that exclude Hoechst 33342 dye are enriched with stem-like cells in several cancer cell lines. In this study, we isolated and characterized SP cells from human Ewing's sarcoma cell line SK-ES-1 in vitro. SP cells were detected in SK-ES-1 and comprised 1.2% of total cell population. Only SP cells had the capacity to regenerate both SP and non-SP cells. The proliferation rates were similar between SP and non-SP cells. However, the clonogenicity and invasiveness of SP cells were significantly higher than that of non-SP cells. Further characterization of this SP phenotype presented other properties. SP cells exhibited increased multi-drug resistance and the ATP binding cassette protein (ABC) transporters were up-regulated in SP population. These findings suggest that SP cells derived from Ewing's sarcoma play the critical role in tumor metastasis and recurrence and might be an ideal target for clinical therapy.

摘要

染料排除法是一种基于干细胞能够排出荧光 DNA 结合染料的能力来分离癌症干细胞 (CSC) 的有价值的技术,特别是对于没有独特表面标记的肿瘤。已经证明,几种癌细胞系中的侧群 (SP) 细胞排斥 Hoechst 33342 染料,富含干细胞样细胞。在这项研究中,我们在体外从人尤文肉瘤细胞系 SK-ES-1 中分离和鉴定了 SP 细胞。SP 细胞在 SK-ES-1 中被检测到,占总细胞群体的 1.2%。只有 SP 细胞具有再生 SP 和非 SP 细胞的能力。SP 细胞和非 SP 细胞的增殖率相似。然而,SP 细胞的克隆形成能力和侵袭性明显高于非 SP 细胞。对这种 SP 表型的进一步特征分析呈现出其他特性。SP 细胞表现出增加的多药耐药性,并且 SP 群体中 ABC 转运蛋白上调。这些发现表明,源自尤文肉瘤的 SP 细胞在肿瘤转移和复发中起关键作用,可能是临床治疗的理想靶点。

相似文献

1
Detection and characterization of side population in Ewing's sarcoma SK-ES-1 cells in vitro.体外检测和鉴定尤因肉瘤 SK-ES-1 细胞中的侧群。
Biochem Biophys Res Commun. 2010 Jan 1;391(1):1062-6. doi: 10.1016/j.bbrc.2009.12.020. Epub 2009 Dec 10.
2
Characterization of cancer stem-like cells derived from a side population of a human gallbladder carcinoma cell line, SGC-996.从人胆囊癌细胞系 SGC-996 的侧群中鉴定出的肿瘤干细胞样细胞的特征。
Biochem Biophys Res Commun. 2012 Mar 23;419(4):728-34. doi: 10.1016/j.bbrc.2012.02.090. Epub 2012 Feb 24.
3
Side population cells in human cancers.人类癌症中的侧群细胞。
Cancer Lett. 2008 Sep 8;268(1):1-9. doi: 10.1016/j.canlet.2008.03.048. Epub 2008 May 19.
4
The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.多药耐药转运蛋白ABCG2(乳腺癌耐药蛋白1)可外排Hoechst 33342,且在造血干细胞中过表达。
Clin Cancer Res. 2002 Jan;8(1):22-8.
5
Detection of putative cancer stem cells of the side population phenotype in human tumor cell cultures.在人肿瘤细胞培养物中检测具有旁群表型的假定癌症干细胞。
Methods Mol Biol. 2012;878:201-15. doi: 10.1007/978-1-61779-854-2_13.
6
Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.人肺癌细胞系和肿瘤中的侧群富含干细胞样癌细胞。
Cancer Res. 2007 May 15;67(10):4827-33. doi: 10.1158/0008-5472.CAN-06-3557.
7
Identification and characterization of side population cells from adult human dental pulp after ischemic culture.鉴定和特征分析经缺血培养后的成人牙髓中的侧群细胞。
J Endod. 2012 Nov;38(11):1489-97. doi: 10.1016/j.joen.2012.08.004. Epub 2012 Sep 21.
8
Tumor recurrence and drug resistance properties of side population cells in high grade ovary cancer.高级别卵巢癌中侧群细胞的肿瘤复发及耐药特性
Drug Res (Stuttg). 2015 Mar;65(3):153-7. doi: 10.1055/s-0034-1375609. Epub 2014 Dec 11.
9
Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin.紫杉醇耐药卵巢癌细胞系中侧群细胞增加,而与顺铂耐药无关。
Gynecol Oncol. 2011 May 1;121(2):390-4. doi: 10.1016/j.ygyno.2010.12.366. Epub 2011 Jan 26.
10
Side population in MDA-MB-231 human breast cancer cells exhibits cancer stem cell-like properties without higher bone-metastatic potential.MDA-MB-231 人乳腺癌细胞中的侧群细胞表现出类似癌症干细胞的特性,而没有更高的骨转移潜力。
Oncol Rep. 2011 Jan;25(1):289-96.

引用本文的文献

1
Splice variants denote differences between a cancer stem cell side population of EWSR1‑ERG‑based Ewing sarcoma cells, its main population and EWSR1‑FLI‑based cells.剪接变异体表示 EWSR1-ERG 为基础的尤文肉瘤细胞、其主要群体和 EWSR1-FLI 为基础的细胞的癌症干细胞侧群之间的差异。
Int J Mol Med. 2022 Mar;49(3). doi: 10.3892/ijmm.2022.5094. Epub 2022 Jan 28.
2
Tumor-propagating side population cells are a dynamic subpopulation in undifferentiated pleomorphic sarcoma.肿瘤增殖性侧群细胞是未分化多形性肉瘤中具有活力的亚群。
JCI Insight. 2021 Nov 22;6(22):e148768. doi: 10.1172/jci.insight.148768.
3
Impact of ABC Transporters in Osteosarcoma and Ewing's Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?
三磷酸腺苷结合盒转运蛋白在骨肉瘤和尤文肉瘤中的作用:哪些与化疗耐药有关,哪些无关?
Cells. 2021 Sep 17;10(9):2461. doi: 10.3390/cells10092461.
4
Cancer Stem Cells as a Source of Drug Resistance in Bone Sarcomas.癌症干细胞作为骨肉瘤耐药性的来源
J Clin Med. 2021 Jun 14;10(12):2621. doi: 10.3390/jcm10122621.
5
Soft Tissue Sarcoma Cancer Stem Cells: An Overview.软组织肉瘤癌症干细胞:概述
Front Oncol. 2018 Oct 26;8:475. doi: 10.3389/fonc.2018.00475. eCollection 2018.
6
Novel molecular insights and new therapeutic strategies in osteosarcoma.骨肉瘤的新型分子见解与新治疗策略
Cancer Cell Int. 2018 Oct 16;18:158. doi: 10.1186/s12935-018-0654-4. eCollection 2018.
7
ROCK1-PredictedmicroRNAs Dysregulation Contributes to Tumor Progression in Ewing Sarcoma.ROCK1 预测的 microRNAs 失调导致尤文肉瘤肿瘤进展。
Pathol Oncol Res. 2020 Jan;26(1):133-139. doi: 10.1007/s12253-017-0374-4. Epub 2017 Dec 21.
8
Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells.克服骨肉瘤的治疗耐药性:骨肉瘤干细胞的分子机制与治疗靶点概述
Stem Cells Int. 2016;2016:2603092. doi: 10.1155/2016/2603092. Epub 2016 Dec 27.
9
Osteosarcoma: mouse models, cell of origin and cancer stem cell.骨肉瘤:小鼠模型、起源细胞与癌症干细胞
Postdoc J. 2014 Feb;2(2):19-30. doi: 10.14304/surya.jpr.v2n2.3.
10
The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute.间充质干/祖细胞在肉瘤中的作用:最新进展与争议
Stem Cell Investig. 2014 Oct 27;1:18. doi: 10.3978/j.issn.2306-9759.2014.10.01. eCollection 2014.